Health Catalyst Inc. announced that its board approved a workforce reduction program, codenamed Project Nexus, on April 24, 2026, with the announcement made public on April 27, 2026. The program will cut the company’s global staff by approximately 9%, or about 100 positions, across technology, professional services, and corporate functions. The Chief People Officer role is being eliminated, with Linda Llewelyn transitioning to a senior advisor position.
The reduction comes amid a challenging macro environment and a recent shift in the company’s revenue mix. Health Catalyst’s Q4 2025 revenue of $74.7 million fell 6.2% from the same quarter last year, while the GAAP net loss widened to $91.0 million from $20.7 million in Q4 2024. The company also reported a non‑GAAP EPS of $0.08, missing the consensus estimate of $0.10. These financial pressures, combined with headwinds from the migration of clients from the legacy DOS platform to the newer Ignite platform, prompted the cost‑control initiative.
Management highlighted that the migration has generated $12.5 million in DOS‑related ARR downsell and churn, with an additional $52 million subject to negotiation. The company’s adjusted gross margin improved to 53.5% in Q4 2025 from 46.6% in the prior year, but the overall financial health remains a concern, with a GF Score™ of 46/100 and a financial strength rating of 3 out of 10. The workforce reduction is intended to align operating expenses with the company’s current revenue trajectory and to preserve cash amid ongoing platform transition costs.
CEO Benjamin Albert, who took the helm in February 2026, emphasized a “back‑to‑basics” approach and a focus on execution. He stated that the company plans to provide full‑year revenue and adjusted EBITDA guidance by the first quarter earnings call in May, signaling a cautious outlook while maintaining confidence in cost discipline. The reduction is expected to deliver significant annual savings in operating expenses, helping to stabilize the company’s balance sheet as it navigates the transition to the Ignite platform.
The announcement reflects a broader trend of cost optimization within the health‑tech sector, where companies are tightening margins and restructuring operations to adapt to shifting demand and competitive pressures. By reducing headcount, Health Catalyst aims to improve profitability and position itself for future growth once the platform migration stabilizes.
The content on EveryTicker is for informational purposes only and should not be construed as financial or investment advice. We are not financial advisors. Consult with a qualified professional before making any investment decisions. Any actions you take based on information from this site are solely at your own risk.